跳至主要内容
临床试验/TCTR20220505005
TCTR20220505005尚未招募1 期

Efficacy and safety of Tongxinluo capsules combined with metoprolol tartrate in the treatment of angina pectoris in coronary heart disease: A study protocol of randomized, double-blind, placebo-controlled clinical trial

Pengcheng Ren0 个研究点目标入组 114 人开始时间: 2022年5月5日最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
114

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • 1.meeting the diagnostic criteria for coronary angina 2. 18 to 70 years old 3.Bruce Protocol 3 to 12 min 4. patients agreed to join this study and signed the informed consent form.

排除标准

  • 1.patients with drug allergy in this study 2. patients with acute cardiomyopathy or congestive heart failure within 3 months 3. ALT, AST or Cr up to 1.5 times the normal upper limit 4. those with communication impairment or poor compliance 5. women who are pregnant, preparing for pregnancy or breastfeeding.

研究者

发起方
Pengcheng Ren

相似试验